[Plexiform fibrohistiocytic tumor: a low grade malignancy lesion].

Tunis Med

Service d'Anatomie et de Cytologie Pathologiques, Hôpital Habib Thameur, Tunis.

Published: September 2003

The plexiform fibrohistiocytic tumor is rare. It affects mainly children and adolescent. This tumor occurs at the dermo-subcutaneous region of the upper extremities. We report a case of a 11 year-old child exhibited a nodule on his forearm who is diagnosed as a plexiform fibrohistiocytic tumor. Histologically, it was a plexiform proliferation of spindle fibroblast-like cells associated with mononuclear histiocyte-like cells. Treatement consisted on a large excision and in the follow-up there is no recurrence of the tumor. 'I'he differential diagnosis may be difficult with other tumors in to the derm or sub-cutaneus adipose tissu, having a plexiform pattern or a predominantly fibroblastic pattern like the fibromatosis and well differenciated fibrosarcoma. This tumor reccured in 20 to 30 % of the cases. Lymph node and pulmonary metastasis are rare. This clinical behaviour leads authors to class it into a "borderline tumor".

Download full-text PDF

Source

Publication Analysis

Top Keywords

fibrohistiocytic tumor
12
plexiform fibrohistiocytic
8
tumor
6
[plexiform fibrohistiocytic
4
tumor low
4
low grade
4
grade malignancy
4
malignancy lesion]
4
plexiform
4
lesion] plexiform
4

Similar Publications

Dermatofibrosarcoma protuberans: A clinical and pathological observational report of Asian samples from one center.

J Cancer Res Ther

December 2024

Department of Plastic and Reconstructive Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Background: Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade fibrohistiocytic tumor with malignant potential. It is considered to have a high local recurrence rate due to the characteristic invasion of the finger-like lesion into the soft tissues.

Method: This retrospective study presents details of 20 DFSP patients with a history of surgery and a long follow-up period.

View Article and Find Full Text PDF
Article Synopsis
  • Soft tissue sarcomas (STSs) make up less than 1% of all malignant tumors in humans, and treatment for metastatic STSs focuses on palliative care due to poor prognosis.
  • A study evaluated the effectiveness of low-dose radiotherapy combined with metronomic therapy in 16 heavily treated patients with metastatic STSs, aiming to assess their response and quality of life.
  • Results showed that 43.75% of patients achieved a partial response, and all reported improved quality of life compared to their previous treatment, demonstrating potential benefits of this combined approach in managing STSs.
View Article and Find Full Text PDF

Dermatofibroma (DF) is a common, benign fibrohistiocytic tumor with unknown pathogenesis. There are multiple uncommon histologic variants of DF reported in literature, one of which is hemosiderotic DF. It can variably present as a pigmented papule or nodule commonly located on the lower extremities.

View Article and Find Full Text PDF

Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis.

Sci Transl Med

September 2024

Department of Surgery, Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.

Article Synopsis
  • Dysregulated skin fibrosis can cause various health issues, including matrix disorders, scarring from injuries, and autoimmune conditions.
  • The text outlines the mechanisms behind cutaneous fibrosis, highlighting the roles of morphogenic signaling, immune responses, and mechanical signaling in influencing fibroblast behavior.
  • There is a need for more effective treatments for skin fibrosis, and recent scientific discoveries are paving the way for new therapeutic options and research opportunities in this area.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!